Literature DB >> 15953429

Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.

Peter Martus1, Andrea Stroux, Wido M Budde, Christian Y Mardin, Matthias Korth, Jost B Jonas.   

Abstract

PURPOSE: To evaluate whether various types of chronic open-angle glaucoma differ in predictive factors for progression of glaucomatous optic nerve damage.
DESIGN: Observational cohort study.
SETTING: Prospective observational clinical study. PATIENTS: 517 eyes of 300 Caucasian patients with chronic open-angle glaucoma with elevated intraocular pressure (primary open-angle glaucoma, n = 289; secondary open-angle glaucoma, n = 50) and with normal intraocular pressure (n = 178). OBSERVATION PROCEDURE: During follow-up (median: 49 months, 6 months-130 months), all patients underwent repeated evaluation of color stereo optic disk photographs and white-on-white visual field examination. MAIN OUTCOME MEASURES: Progression of glaucoma was defined as neuroretinal rim loss during the study period.
RESULTS: For patients with elevated intraocular pressure, significantly predictive factors for eventual progression were older age, advanced perimetric damage, smaller neuroretinal rim, and larger area of beta zone of parapapillary atrophy. In contrast, in the normal intraocular pressure group, a significant predictive factor was presence of disk hemorrhages at baseline. Within the patients with elevated intraocular pressure, the primary open-angle glaucoma group and the secondary open-angle glaucoma group did not differ in predictive factors for progression of glaucoma.
CONCLUSIONS: Open-angle glaucoma patients with normal intraocular pressure and open-angle glaucoma patients with elevated intraocular pressure differ in predictive factors for eventual progression of glaucomatous optic nerve damage. It may have clinical importance and may be helpful in the discussion of the pathogenesis of the glaucomas.

Entities:  

Mesh:

Year:  2005        PMID: 15953429     DOI: 10.1016/j.ajo.2004.12.056

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  [Structural diagnostics of course observation for glaucoma].

Authors:  C Y Mardin
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

3.  Beta-zone parapapillary atrophy and multifocal visual evoked potentials in eyes with glaucomatous optic neuropathy.

Authors:  Carlos Gustavo De Moraes; Scott Ketner; Christopher C Teng; Joshua R Ehrlich; Ali S Raza; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  Doc Ophthalmol       Date:  2011-07-07       Impact factor: 2.379

4.  Transcriptional profiling analysis predicts potential biomarkers for glaucoma: HGF, AKR1B10 and AKR1C3.

Authors:  Qiaoli Nie; Xiaoyan Zhang
Journal:  Exp Ther Med       Date:  2018-10-17       Impact factor: 2.447

5.  Comparison of retinal microvascular changes in eyes with high-tension glaucoma or normal-tension glaucoma: a quantitative optic coherence tomography angiographic study.

Authors:  Huan Xu; Ruyi Zhai; Yuan Zong; Xiangmei Kong; Chunhui Jiang; Xinghuai Sun; Yi He; Xiqi Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-15       Impact factor: 3.117

6.  Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma.

Authors:  Cathy Nguyen; Frances E Cone; Thao D Nguyen; Baptiste Coudrillier; Mary E Pease; Matthew R Steinhart; Ericka N Oglesby; Joan L Jefferys; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

7.  Stereoscopic analysis of optic nerve head parameters in primary open angle glaucoma: the glaucoma stereo analysis study.

Authors:  Yu Yokoyama; Masaki Tanito; Koji Nitta; Maki Katai; Yasushi Kitaoka; Kazuko Omodaka; Satoru Tsuda; Toshiaki Nakagawa; Toru Nakazawa
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

8.  Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma.

Authors:  Martina Tomić; Snježana Kaštelan; Kata Metež Soldo; Jasminka Salopek-Rabatić
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

9.  The management of glaucoma and intraocular hypertension: current approaches and recent advances.

Authors:  Robert J Noecker
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

10.  Characteristics of patients with primary open angle glaucoma and normal tension glaucoma at a university hospital: a cross-sectional retrospective study.

Authors:  Yu Yokoyama; Kazuichi Maruyama; Hideyuki Konno; Sayaka Hashimoto; Mai Takahashi; Hiroko Kayaba; Taiki Kokubun; Toru Nakazawa
Journal:  BMC Res Notes       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.